The shift from treatment to prevention creates an opening AHA must own. Wearable sensors, AI diagnostics, and consumer health platforms are reshaping how people relate to their own health — daily, not annually.

AHA’s 2030 Impact Goal to increase healthy life expectancy requires reaching populations that don’t attend galas. Moving the needle from 66 to 68 years of healthy life means engaging the hardest-to-reach, not the easiest-to-invite.

The evidence spine — the published figures behind every finding in this brief.

Network analysis of public discourse (95 nodes, 273 edges, modularity 0.66 across 7 clusters) shows attention concentrating in Health Insights (47% betweenness) while AHA's strategic priorities — AI, behavior change, women's health — sit in structurally disconnected clusters. By mapping the topology of conversation, we identify the structural gaps where opportunity lives.

Discourse clusters ranked by betweenness centrality — where attention actually concentrates in the public conversation around AHA, cardiovascular health, and women's health.

Core knowledge gateway connecting all strategic domains. The bridge between research output and public understanding — nearly half the map's connective tissue.

Emerging technology cluster, structurally isolated from Behavior Change — the primary strategic disconnect in AHA's graph.

Grant allocation and NIH partnerships. Critical pipeline for scientific credibility and institutional authority.

Three primary structural gaps identified through knowledge-graph analysis — each a place where attention, infrastructure, and mission fail to connect.

AHA has invested over $6.1B in research, yet community engagement is declining. The research-to-impact pipeline is broken — scientific breakthroughs don't translate into behavioral change at scale. The people who most need AHA's science are the least likely to encounter it in a form they can act on.

AHA published guidance on AI best practices in cardiovascular care but has no consumer-facing technology platform. Google, Apple, and Whoop are building the daily health relationships AHA aspires to.

AHA has not connected its AI vision to its women's health mandate. AI-powered wearables could revolutionize maternal cardiovascular monitoring, but this bridge doesn't exist in current programming — wide-open territory, perfectly aligned with the mission.

The complete evidence base behind the three primary findings — ten gaps across four categories.

AHA wants to be a lifelong health partner but has no continuous engagement mechanism. Annual campaigns and luncheons cannot build daily trust. The shift from episodic authority to persistent relationship requires an entirely different operating model.

No consumer-facing digital product. Wearable companies own the daily health relationship AHA wants. AHA certifies devices and publishes guidance but has no surface where a person interacts with AHA-powered health intelligence every day.

National campaigns in a world where health trust is local. Go Red is one-size-fits-all when personalization is expected. Communities that need AHA most — rural, underresourced, non-English-speaking — are least served by the current model.

BCTO (Behavior Change Technique Ontology) and health communication models exist but are absent from AHA’s public-facing programs. The science of changing health behavior is mature — AHA has not operationalized it beyond clinical recommendations.

Campaign recognition is lowest among the most vulnerable populations. No digital-native engagement pathway exists. Women under 40 — the cohort where early intervention has the most impact — are invisible in AHA’s engagement data.

Men are absent from women’s heart health discourse. No activation model for partners, sons, fathers. Heart disease in women affects entire families, but AHA’s messaging treats it as a women-only conversation.

Social determinants of health (SDOH) framework is referenced in AHA communications but not operationalized in community programming. Equity remains a talking point rather than a delivery mechanism.

Personal agency is acknowledged as a healthcare trend but AHA provides no tools for self-management. People are tracking their own health data daily; AHA has no framework for helping them interpret or act on it.

Health equity messaging does not reach populations who don’t attend galas or Red Dress concerts. AHA’s fundraising model self-selects for affluent audiences, creating a structural blind spot for the communities with the highest cardiovascular risk.

AHA has clinician education programs but a weak clinician-to-patient advocacy pipeline for women’s specific risks. Doctors trust AHA; patients trust their doctors. This chain of trust is underutilized as a delivery mechanism for women’s heart health.

Five questions this analysis surfaces — the agenda for what AHA should be asking next.

AHA against the companies that own the daily health relationship — strongest where it matters least to daily life, absent where the competition lives.

Six moves, ranked by leverage — what the network analysis says AHA should do first.

Our analysis reveals that the Heart-Check mark has become a pay-to-play certification. Large CPG companies pay significant fees to display it — and many certified products (certain sugary cereals, processed grains) meet technical criteria for low fat/cholesterol but are high in refined carbohydrates. Commission an independent review of every Heart-Check product against current metabolic science (not just legacy lipid criteria). Sunset certifications that no longer align with AHA’s own research on cardiovascular risk. The short-term revenue hit is real — but the long-term credibility gain is the only currency that matters for a 100-year brand.

AHA brand awareness sits at ~92%. Adult obesity is at ~42%. Hypertension is rising. Awareness is a vanity metric — people know heart disease is bad; they know AHA exists. But awareness doesn’t change the price of a salad vs. a burger, and it doesn’t reach food deserts. Redirect a meaningful percentage of awareness-campaign spend into behavioral efficacy programs — interventions measured by health outcomes (blood pressure reduction, A1C change), not impressions. Pilot in 3 cities. Publish results. Let the data make the case for scaling.

The 400+ annual Heart Ball events are high-cost “Positive Space” — black ties, expensive venues, recognition awards. For every dollar raised, a significant portion is consumed by production overhead. These events serve donor ego more than patient need. Pick 10 local chapters. Run A/B tests: traditional gala vs. a new “Social Impact Investor” model where donors receive measurable outcomes data (e.g., “Your $50K funded 200 community blood pressure screenings, resulting in 34 early interventions”). Measure donor retention, cost-per-dollar-raised, and downstream health impact. Let the numbers decide which model wins.

Apple, Google, and Whoop own the daily health relationship AHA aspires to. AHA publishes wearable guidelines but has no surface where a person interacts with AHA-powered intelligence every day. Launch an RFP for a technology partnership — not a logo-on-a-device deal, but a co-developed platform where AHA’s cardiovascular science powers the interpretation layer for wearable data. The unique selling proposition: “Your Apple Watch collects the data. AHA tells you what it means.” No competitor can match AHA’s scientific authority in this space.

AHA expanded into maternal health in its 2024–2028 policy agenda, but has not bridged this to its digital health vision. AI-powered wearables could revolutionize maternal cardiovascular monitoring — detecting pre-eclampsia risk, gestational hypertension, and postpartum cardiomyopathy earlier than any current clinical protocol. Fund a dedicated research track: “AI-Enabled Maternal Heart Health.” Partner with an academic medical center and a wearable manufacturer. Own this intersection before anyone else does — it aligns perfectly with Go Red’s evolution and addresses the clinical trial gender gap (women make up just 38% of cardiovascular trial participants, per AHA’s own Circulation study).

AHA has significant policy influence but deploys it primarily for awareness campaigns and research funding. The systemic levers — food policy, urban design, sugar subsidies — remain underused. Allocate lobbying resources toward three concrete infrastructure targets: (1) federal tax incentives for fresh-produce availability in food deserts, (2) municipal “walkability” mandates in new development, (3) rebalancing agricultural subsidies away from corn syrup toward whole foods. These are the “Negative Space” moves — unsexy, systemic, and far more impactful than another red dress.

AHA is trusted as a scientific authority, but trust is passive — people believe AHA but don't act on that belief. The Trust-to-Engagement conversion gap is the critical vulnerability, and trust is eroding among younger demographics.

The public understands AHA's mission but doesn't feel personally connected to it. The mission feels institutional, not personal; the prevention message is too generic, with no 'what's in it for me' framing.

The smoking gun of the engagement gap: people trust AHA but aren't loyal to it. The Trust (3.7) to Loyalty (2.8) drop is the single biggest strategic opportunity — NPS is declining and no retention mechanism exists beyond donations.

AHA is uniquely positioned to be that bridge.